PCM
CYNA

Prelude Capital Management’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Prelude Capital Management’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-12,352
Closed -$497K – 1991
2016
Q3 		$497K Buy
+12,352
New +$305K 0.05% 316

Prelude Capital Management's CYNA Position: Q4 2016 in Review

Prelude Capital Management sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 12,352 shares — an estimated $497K sold.

Prelude Capital Management first reported a position in CYNA in Q3 2016 and held it in 1 quarter. The position peaked at $497K in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

  • Prelude Capital Management reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
  • Prelude Capital Management sold 12,352 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $497K.
  • Prelude Capital Management first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2016 and held it in 1 quarter.
  • Prelude Capital Management's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $497K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Prelude Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.